70 results
8-K
EX-10.1
aa59f 8sabwu
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-10.1
06zk3otb1ie zw
4 Jun 21
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-10.1
fagngm96af9s8s54rj
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.1
6jhub
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
ns3d4ut j8fxoltaf
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.1
4zjkdi
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-2.1
bl3u2n
14 Apr 14
Entry into a Material Definitive Agreement
12:00am